Welcome to our dedicated page for Agrify SEC filings (Ticker: AGFY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Agrify Corporation filings, later filed under RYTHM, Inc., document the issuer’s transition from cultivation-related operations toward a THC brand and intellectual-property business. The record includes 8-K disclosures for operating results, material agreements, brand and recipe licensing arrangements, Nasdaq listing matters, and capital-structure items involving common stock, warrants, and convertible notes.
Proxy materials cover annual meeting voting matters, director elections, auditor ratification, and amendments to the company’s equity incentive plan. The filings also describe relationships involving licensed cannabis and THC-related brands, emerging-growth-company status, governance structure, and formal disclosures tied to revenue recognition, regulatory constraints, and public-company reporting obligations.
RYTHM, Inc. reported a sharp turnaround in the quarter ended March 31, 2026 as it executed its shift from cannabis equipment to hemp-derived THC brands and licensing. Revenue from continuing operations rose to $13.3 million from $0.5 million a year earlier, driven mainly by $10.0 million of licensing revenue and $3.3 million of product sales.
The company posted net income of $19.9 million versus a prior-year loss, largely due to a $25.6 million income tax benefit from releasing a valuation allowance after amending its Green Thumb license to a fixed-fee structure. That amendment entitles RYTHM to $70 million per year of fixed license payments, recognized ratably over the term.
Cash and cash equivalents were $33.3 million, and operating activities generated $1.0 million of cash. Total assets reached $127.5 million and stockholders’ equity increased to $36.6 million. The balance sheet also shows $80.6 million of debt, including $72.0 million of related-party convertible notes classified as current, and the business is highly concentrated in a related-party customer that represented 75% of Q1 revenue.
RYTHM, Inc. reported a sharp turnaround in the quarter ended March 31, 2026 as it executed its shift from cannabis equipment to hemp-derived THC brands and licensing. Revenue from continuing operations rose to $13.3 million from $0.5 million a year earlier, driven mainly by $10.0 million of licensing revenue and $3.3 million of product sales.
The company posted net income of $19.9 million versus a prior-year loss, largely due to a $25.6 million income tax benefit from releasing a valuation allowance after amending its Green Thumb license to a fixed-fee structure. That amendment entitles RYTHM to $70 million per year of fixed license payments, recognized ratably over the term.
Cash and cash equivalents were $33.3 million, and operating activities generated $1.0 million of cash. Total assets reached $127.5 million and stockholders’ equity increased to $36.6 million. The balance sheet also shows $80.6 million of debt, including $72.0 million of related-party convertible notes classified as current, and the business is highly concentrated in a related-party customer that represented 75% of Q1 revenue.
RYTHM, Inc. reported strong top-line growth for the first quarter of 2026, with revenue rising to $13,286 thousand from $538 thousand a year earlier. Gross profit reached $10,397 thousand on significantly higher sales.
The company posted net income from continuing operations of $19,922 thousand, driven largely by an income tax benefit of $25,593 thousand. On an operating basis, RYTHM recorded an EBITDA loss of $486 thousand and Adjusted EBITDA of $(21) thousand, nearly breakeven.
RYTHM ended March 31, 2026 with $33,261 thousand in cash and cash equivalents and generated $1,043 thousand of cash from operating activities in the quarter. Management highlighted 24% sequential revenue growth, a 78% gross margin, and brand leadership across key THC categories, while noting regulatory uncertainty around a potential federal hemp ban.
RYTHM, Inc. reported strong top-line growth for the first quarter of 2026, with revenue rising to $13,286 thousand from $538 thousand a year earlier. Gross profit reached $10,397 thousand on significantly higher sales.
The company posted net income from continuing operations of $19,922 thousand, driven largely by an income tax benefit of $25,593 thousand. On an operating basis, RYTHM recorded an EBITDA loss of $486 thousand and Adjusted EBITDA of $(21) thousand, nearly breakeven.
RYTHM ended March 31, 2026 with $33,261 thousand in cash and cash equivalents and generated $1,043 thousand of cash from operating activities in the quarter. Management highlighted 24% sequential revenue growth, a 78% gross margin, and brand leadership across key THC categories, while noting regulatory uncertainty around a potential federal hemp ban.
RYTHM, Inc. is asking stockholders to vote at its virtual Annual Meeting on June 16, 2026. Owners of 2,149,128 shares of Common Stock as of April 20, 2026 can elect seven directors, ratify GuzmanGray as auditor for 2026, and approve an amendment to the 2022 Omnibus Equity Incentive Plan.
The equity plan amendment would add 115,000 shares to the pool available for stock-based awards to employees, officers, directors and consultants, on top of existing remaining capacity. The proxy statement also details board structure, committee memberships, director compensation, executive pay and the company’s governance and compliance policies.
RYTHM, Inc. is asking stockholders to vote at its virtual Annual Meeting on June 16, 2026. Owners of 2,149,128 shares of Common Stock as of April 20, 2026 can elect seven directors, ratify GuzmanGray as auditor for 2026, and approve an amendment to the 2022 Omnibus Equity Incentive Plan.
The equity plan amendment would add 115,000 shares to the pool available for stock-based awards to employees, officers, directors and consultants, on top of existing remaining capacity. The proxy statement also details board structure, committee memberships, director compensation, executive pay and the company’s governance and compliance policies.
RYTHM, Inc. amended two trademark and recipe license agreements with Green Thumb Industries’ subsidiary GTI Core. Effective April 1, 2026, GTI Core will pay an annual cash fee of $64.0 million for brands including RYTHM, Beboe, Dogwalkers, Doctor Solomon’s, &Shine and Good Green, replacing a sales-based royalty, with CPI-linked increases capped at 10% per year.
For the incredibles brand, GTI Core will pay an additional fixed annual cash fee of $6.0 million, also CPI-linked with a 10% cap. A company press release states these changes result in an aggregate fixed annual cash fee of $70 million from Green Thumb and were made following discussions with Nasdaq staff to support compliance with Nasdaq Capital Market listing standards related to revenue from the federally illegal cannabis industry.
RYTHM, Inc. amended two trademark and recipe license agreements with Green Thumb Industries’ subsidiary GTI Core. Effective April 1, 2026, GTI Core will pay an annual cash fee of $64.0 million for brands including RYTHM, Beboe, Dogwalkers, Doctor Solomon’s, &Shine and Good Green, replacing a sales-based royalty, with CPI-linked increases capped at 10% per year.
For the incredibles brand, GTI Core will pay an additional fixed annual cash fee of $6.0 million, also CPI-linked with a 10% cap. A company press release states these changes result in an aggregate fixed annual cash fee of $70 million from Green Thumb and were made following discussions with Nasdaq staff to support compliance with Nasdaq Capital Market listing standards related to revenue from the federally illegal cannabis industry.
RSLGH, LLC, a wholly owned indirect subsidiary of Green Thumb Industries Inc. and a ten percent owner of RYTHM, Inc., exercised pre-funded warrants to acquire 78,459 shares of common stock. The warrants carried an exercise price of $0.001 per share and were originally issued as payment of interest on a Convertible Note dated August 25, 2025. The pre-funded warrants and their exercise are subject to a 49.99% beneficial ownership limitation and to stockholder approval under applicable Nasdaq listing rules, to the extent required. Following this derivative exercise, RSLGH directly holds 78,459 shares of RYTHM common stock reported in this filing.
RSLGH, LLC, a wholly owned indirect subsidiary of Green Thumb Industries Inc. and a ten percent owner of RYTHM, Inc., exercised pre-funded warrants to acquire 78,459 shares of common stock. The warrants carried an exercise price of $0.001 per share and were originally issued as payment of interest on a Convertible Note dated August 25, 2025. The pre-funded warrants and their exercise are subject to a 49.99% beneficial ownership limitation and to stockholder approval under applicable Nasdaq listing rules, to the extent required. Following this derivative exercise, RSLGH directly holds 78,459 shares of RYTHM common stock reported in this filing.
Green Thumb Industries Inc. and affiliated entities report beneficial ownership of 49.99% of RYTHM, Inc.’s common stock. They are deemed to control 13,290,387 shares through a mix of owned stock, convertible notes and multiple warrant series, all subject to ownership caps.
On March 9, 2026, RYTHM issued new Interest Warrants exercisable for up to 78,459 shares as a payment of interest under the August 2025 secured convertible note. The reporting group indicates that, to the extent their actions are viewed as a control purpose, they may engage with management and the board on capitalization, ownership structure and potential business combinations or dispositions.
Green Thumb Industries Inc. and affiliated entities report beneficial ownership of 49.99% of RYTHM, Inc.’s common stock. They are deemed to control 13,290,387 shares through a mix of owned stock, convertible notes and multiple warrant series, all subject to ownership caps.
On March 9, 2026, RYTHM issued new Interest Warrants exercisable for up to 78,459 shares as a payment of interest under the August 2025 secured convertible note. The reporting group indicates that, to the extent their actions are viewed as a control purpose, they may engage with management and the board on capitalization, ownership structure and potential business combinations or dispositions.
RYTHM, Inc. files its annual report describing a transformed business focused on hemp-derived THC beverages and licensed cannabis brands after exiting cultivation and extraction. The company changed its name from Agrify Corporation and now relies heavily on shared services from Green Thumb affiliates.
RYTHM highlights major secured convertible notes totaling $80.0 million outstanding as of December 31, 2025, against cash and equivalents of $32.2 million. Non-affiliate market value was $26,690,756 based on a $21.17 share price, with 2,149,148 shares outstanding as of March 3, 2026.
The report stresses substantial regulatory risk: the 2026 Appropriations Act would, after a 365‑day grace period, effectively prohibit its current hemp-derived THC products and could trigger repurchase rights over key brand IP. Extensive risk factors also cover federal and state enforcement uncertainty, dependence on Green Thumb-related parties, competitive pressure, and the potential need for additional financing to meet debt obligations.
RYTHM, Inc. files its annual report describing a transformed business focused on hemp-derived THC beverages and licensed cannabis brands after exiting cultivation and extraction. The company changed its name from Agrify Corporation and now relies heavily on shared services from Green Thumb affiliates.
RYTHM highlights major secured convertible notes totaling $80.0 million outstanding as of December 31, 2025, against cash and equivalents of $32.2 million. Non-affiliate market value was $26,690,756 based on a $21.17 share price, with 2,149,148 shares outstanding as of March 3, 2026.
The report stresses substantial regulatory risk: the 2026 Appropriations Act would, after a 365‑day grace period, effectively prohibit its current hemp-derived THC products and could trigger repurchase rights over key brand IP. Extensive risk factors also cover federal and state enforcement uncertainty, dependence on Green Thumb-related parties, competitive pressure, and the potential need for additional financing to meet debt obligations.
RYTHM, Inc. received an updated Schedule 13D/A showing that a group of related entities led by Green Thumb Industries Inc. collectively reports beneficial ownership of 13,211,928 shares of common stock, or 49.99% of the company, based on 2,149,148 shares outstanding as of March 1, 2026.
This stake includes previously acquired common shares, secured convertible notes and multiple series of warrants, many of which are subject to 4.99% or 49.99% beneficial ownership limits and Nasdaq-related conversion and exercise restrictions. On March 1, 2026, the company also issued new Interest Warrants for up to 57,377 shares as an interest payment under a May 2025 note.
The reporting group states that its actions may be deemed to have a control purpose and indicates it may engage with management, the board and other shareholders on capitalization, ownership structure, board composition, and potential business combinations or dispositions, as well as consider buying or selling additional securities.
RYTHM, Inc. received an updated Schedule 13D/A showing that a group of related entities led by Green Thumb Industries Inc. collectively reports beneficial ownership of 13,211,928 shares of common stock, or 49.99% of the company, based on 2,149,148 shares outstanding as of March 1, 2026.
This stake includes previously acquired common shares, secured convertible notes and multiple series of warrants, many of which are subject to 4.99% or 49.99% beneficial ownership limits and Nasdaq-related conversion and exercise restrictions. On March 1, 2026, the company also issued new Interest Warrants for up to 57,377 shares as an interest payment under a May 2025 note.
The reporting group states that its actions may be deemed to have a control purpose and indicates it may engage with management, the board and other shareholders on capitalization, ownership structure, board composition, and potential business combinations or dispositions, as well as consider buying or selling additional securities.